{
  "docId": "019de074-ead2-732b-8415-93449fe93e32",
  "docSlug": "9cc66a7a8f583a45c6978147aa12db97",
  "documentTitle": "Freeman Capital Management | Activist Presentation Deck | 95 slides",
  "authorId": "freeman-capital-management",
  "authorName": "Freeman Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 95,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "timeline",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-ead2-732b-8415-93449fe93e32/9",
  "deckHref": "/decks/019de074-ead2-732b-8415-93449fe93e32",
  "deckJsonHref": "/decks/019de074-ead2-732b-8415-93449fe93e32.json",
  "deckAnchorHref": "/decks/019de074-ead2-732b-8415-93449fe93e32#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "list",
      "text": "June 2021 - May 2022: Dr. Freeman reached out to the Board to discuss many of the problems afflicting MindMed that persist today. MindMed provided no substantive response and mischaracterizes his offers to serve on the Board as a request of entitlement.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8401fad4-a117-4f96-9f4e-0486c4b826b5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "July 2019: Dr. Freeman co-founded MindMed and became Chief Medical Officer and Executive President of MindMed.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "921e42ce-7f0f-4ea7-917d-5a2c4f3e2d10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.5,
        "y": 0.25
      },
      "kind": "list",
      "text": "August 2020: Dr. Freeman developed MindMed's clinical framework, recruited key employees, and created the collaboration with the University Hospital Basel. Dr. Freeman left the Company and is subject to confidentiality agreement.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbd8face-1338-4ff0-a4ce-081c030e642b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.5,
        "y": 0.55
      },
      "kind": "list",
      "text": "August 2022: After over two years of quietly attempting to engage with MindMed, FCM was formed. FCM outlined its concerns in a public letter to the Board outlining its Value Enhancement Plan which outlined a plan for enhanced capital allocation, industry standard drug development, cutting executive compensation, and using shareholder equity judiciously.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc5063bf-0b77-4605-8e06-c28f27986dbd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Our History of Engagement",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85ab5f9f-c487-4008-8b9d-f84f69b1827e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "2580f257-afc1-4119-b581-86fa3b85c5dc",
      "evidence": "Chronological presentation of events",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 7,
      "beatId": "85b7cc19-6bf1-4224-9106-c9aec7c4aad5",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The document identifies the company's severe market underperformance and flawed approach to clinical development as key problems.",
      "position": 0,
      "confidence": 0.9,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "736778a8-67e9-479d-853c-8d29821dfcab",
      "evidence": "The document highlights the company's severe market underperformance and the need for change.",
      "position": 0,
      "objective": "What is the cost of inaction for Mind Medicine's shareholders?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.8,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}